BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

606 related articles for article (PubMed ID: 19453047)

  • 1. Survival and prognostic factors analysis in surgically resected gastrointestinal stromal tumor patients.
    Song Z; Wang JL; Pan YL; Tao DY; Gan MF; Huang KE
    Hepatogastroenterology; 2009; 56(89):149-53. PubMed ID: 19453047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Multivariate analysis of prognosis in gastrointestinal stromal tumor].
    Bai YK; Shao YF; Shi SS; Gao YN; Sun YT; Cheng SJ; Liu XY
    Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):598-601. PubMed ID: 16438868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic analysis of patients with gastrointestinal stromal tumors: a single unit experience with surgical treatment of primary disease.
    Cao H; Zhang Y; Wang M; Shen DP; Sheng ZY; Ni XZ; Wu ZY; Liu Q; Shen YY; Song YY
    Chin Med J (Engl); 2010 Jan; 123(2):131-6. PubMed ID: 20137358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic stratification of high-risk gastrointestinal stromal tumors in the era of targeted therapy.
    Keun Park C; Lee EJ; Kim M; Lim HY; Choi DI; Noh JH; Sohn TS; Kim S; Kim MJ; Lee HK; Kim KM
    Ann Surg; 2008 Jun; 247(6):1011-8. PubMed ID: 18520229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different factors are responsible for predicting relapses after primary tumors resection and for imatinib treatment outcomes in gastrointestinal stromal tumors.
    Rutkowski P; Debiec-Rychter M; Nowecki ZI; Wozniak A; Michej W; Limon J; Siedlecki JA; Jerzak Vel Dobosz A; Grzesiakowska U; Nasierowska-Guttmejer A; Sygut J; Nyckowski P; Krawczyk M; Ruka W
    Med Sci Monit; 2007 Nov; 13(11):CR515-522. PubMed ID: 17968300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of clinicopathology and prognosis in 181 patients with gastrointestinal stromal tumors].
    Zhang Y; Cao H; Wang M; Shen DP; Shen ZY; Ni XZ; Wu ZY; Shen YY; Liu Q
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Mar; 12(2):150-4. PubMed ID: 19296250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of prognostic and clinicopathologic factors in gastrointestinal stromal tumors of the stomach].
    Bai YK; Shao YF; Cao WL; Shi SS; Yu LW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Jan; 10(1):21-5. PubMed ID: 17253167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of KIT-negative gastrointestinal stromal tumours and diagnostic utility of protein kinase C theta immunostaining.
    Lee HE; Kim MA; Lee HS; Lee BL; Kim WH
    J Clin Pathol; 2008 Jun; 61(6):722-9. PubMed ID: 18381383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk criteria and prognostic factors for predicting recurrences after resection of primary gastrointestinal stromal tumor.
    Rutkowski P; Nowecki ZI; Michej W; Debiec-Rychter M; Woźniak A; Limon J; Siedlecki J; Grzesiakowska U; Kakol M; Osuch C; Polkowski M; Głuszek S; Zurawski Z; Ruka W
    Ann Surg Oncol; 2007 Jul; 14(7):2018-27. PubMed ID: 17473953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The abnormalities in the p53/p21WAF1 pathway have a significant role in the pathogenesis and progression of gastrointestinal stromal tumors.
    Chou YP; Lin JW; Wang CC; Chiu YC; Huang CC; Chuah SK; Tai MH; Yi LN; Lee CM; Changchien CS; Hu TH
    Oncol Rep; 2008 Jan; 19(1):49-56. PubMed ID: 18097575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal mesenchymal tumors - from smooth muscle tumors to stromal tumors.
    Tai WC; Chuah SK; Lin JW; Chen HH; Huang HY; Kuo CM; Yi LN; Lee CM; Changchien CS; Hu TH
    Oncol Rep; 2008 Nov; 20(5):1157-64. PubMed ID: 18949416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletions affecting codons 557-558 of the c-KIT gene indicate a poor prognosis in patients with completely resected gastrointestinal stromal tumors: a study by the Spanish Group for Sarcoma Research (GEIS).
    Martín J; Poveda A; Llombart-Bosch A; Ramos R; López-Guerrero JA; García del Muro J; Maurel J; Calabuig S; Gutierrez A; González de Sande JL; Martínez J; De Juan A; Laínez N; Losa F; Alija V; Escudero P; Casado A; García P; Blanco R; Buesa JM;
    J Clin Oncol; 2005 Sep; 23(25):6190-8. PubMed ID: 16135486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.
    Miettinen M; Sobin LH; Lasota J
    Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST).
    Dematteo RP; Gold JS; Saran L; Gönen M; Liau KH; Maki RG; Singer S; Besmer P; Brennan MF; Antonescu CR
    Cancer; 2008 Feb; 112(3):608-15. PubMed ID: 18076015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Roles of risk assessment and Ki-67 index in judging prognostic of gastrointestinal stromal tumors].
    Liang YM; Li XH; Chen W
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(15):1041-5. PubMed ID: 18754437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis of gastrointestinal stromal tumors.
    Bertin M; Angriman I; Scarpa M; Mencarelli R; Ranzato R; Ruffolo C; Polese L; Iacobone M; D'Amico DF
    Hepatogastroenterology; 2007; 54(73):124-8. PubMed ID: 17419245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical utility of the new American Joint Committee on Cancer staging system for gastrointestinal stromal tumors: current overall survival after primary tumor resection.
    Rutkowski P; Wozniak A; Dębiec-Rychter M; Kąkol M; Dziewirski W; Zdzienicki M; Ptaszynski K; Jurkowska M; Limon J; Siedlecki JA
    Cancer; 2011 Nov; 117(21):4916-24. PubMed ID: 21456019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical outcomes and immunohistochemical features for gastrointestinal stromal tumors (GISTS) of the stomach: with special reference to prognostic factors.
    Park SS; Ryu JS; Oh SY; Kim WB; Lee JH; Chae YS; Kim SJ; Kim CS; Mok YJ
    Hepatogastroenterology; 2007; 54(77):1454-7. PubMed ID: 17708275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated p21 expression is associated with poor prognosis of rectal stromal tumors after resection.
    Hu TH; Tai MH; Chuah SK; Chen HH; Lin JW; Huang HY; Chou YP; Yi LN; Kuo CM; Changchien CS
    J Surg Oncol; 2008 Aug; 98(2):117-23. PubMed ID: 18521824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical expression of p16INK4A, Ki-67, and Mcm2 proteins in gastrointestinal stromal tumors: prognostic implications and correlations with risk stratification of NIH consensus criteria.
    Huang HY; Huang WW; Lin CN; Eng HL; Li SH; Li CF; Lu D; Yu SC; Hsiung CY
    Ann Surg Oncol; 2006 Dec; 13(12):1633-44. PubMed ID: 17013685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.